Search

Sandra L. Wegert

Examiner (ID: 8720)

Most Active Art Unit
1647
Art Unit(s)
1647, 1646
Total Applications
523
Issued Applications
157
Pending Applications
99
Abandoned Applications
267

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7811443 [patent_doc_number] => 08133974 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-13 [patent_title] => 'Ferroportin1 nucleic acids, proteins, antibodies and methods' [patent_app_type] => utility [patent_app_number] => 12/381770 [patent_app_country] => US [patent_app_date] => 2009-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 21144 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/133/08133974.pdf [firstpage_image] =>[orig_patent_app_number] => 12381770 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/381770
Ferroportin1 nucleic acids, proteins, antibodies and methods Mar 15, 2009 Issued
Array ( [id] => 5386531 [patent_doc_number] => 20090227776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR' [patent_app_type] => utility [patent_app_number] => 12/393224 [patent_app_country] => US [patent_app_date] => 2009-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 56650 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20090227776.pdf [firstpage_image] =>[orig_patent_app_number] => 12393224 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/393224
COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR Feb 25, 2009 Abandoned
Array ( [id] => 5386533 [patent_doc_number] => 20090227778 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'STABLE CELL LINES EXPRESSING HERG1A AND HERG1B' [patent_app_type] => utility [patent_app_number] => 12/388384 [patent_app_country] => US [patent_app_date] => 2009-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6952 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20090227778.pdf [firstpage_image] =>[orig_patent_app_number] => 12388384 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/388384
Stable cell lines expressing HERG1a and HERG1b Feb 17, 2009 Issued
Array ( [id] => 5502190 [patent_doc_number] => 20090162878 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'METHODS AND COMPOSITIONS FOR DETECTING AND QUANTIFYING SAPPB' [patent_app_type] => utility [patent_app_number] => 12/353162 [patent_app_country] => US [patent_app_date] => 2009-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 10978 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20090162878.pdf [firstpage_image] =>[orig_patent_app_number] => 12353162 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/353162
METHODS AND COMPOSITIONS FOR DETECTING AND QUANTIFYING SAPPB Jan 12, 2009 Abandoned
Array ( [id] => 5479609 [patent_doc_number] => 20090202566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'Use of the ENDO-180 gene and polypeptide for diagnosis and treatment' [patent_app_type] => utility [patent_app_number] => 12/317231 [patent_app_country] => US [patent_app_date] => 2008-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13382 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20090202566.pdf [firstpage_image] =>[orig_patent_app_number] => 12317231 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/317231
Use of the ENDO-180 gene and polypeptide for diagnosis and treatment Dec 18, 2008 Abandoned
Array ( [id] => 5515384 [patent_doc_number] => 20090215691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'NOGO Receptor Antagonists' [patent_app_type] => utility [patent_app_number] => 12/335328 [patent_app_country] => US [patent_app_date] => 2008-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 23683 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215691.pdf [firstpage_image] =>[orig_patent_app_number] => 12335328 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/335328
Nogo receptor antagonists Dec 14, 2008 Issued
Array ( [id] => 6534863 [patent_doc_number] => 20100204115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'USE OF ACETYL- (ALA10, 11)-RANTES (1-14) AND/OR CALCITONIN AS ANTI-ANGIOGENIC AGENTS' [patent_app_type] => utility [patent_app_number] => 12/677544 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35824 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204115.pdf [firstpage_image] =>[orig_patent_app_number] => 12677544 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/677544
USE OF ACETYL- (ALA10, 11)-RANTES (1-14) AND/OR CALCITONIN AS ANTI-ANGIOGENIC AGENTS Sep 8, 2008 Abandoned
Array ( [id] => 6326940 [patent_doc_number] => 20100197603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'USE OF RGDSPASSKP AND OPTIONALLY ANGIOTENSIN II AS THERAPEUTIC AGENTS IN THE TREATMENT OF EG S. PNEUMONIAE INFECTIONS' [patent_app_type] => utility [patent_app_number] => 12/676927 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36020 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20100197603.pdf [firstpage_image] =>[orig_patent_app_number] => 12676927 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/676927
USE OF RGDSPASSKP AND OPTIONALLY ANGIOTENSIN II AS THERAPEUTIC AGENTS IN THE TREATMENT OF EG S. PNEUMONIAE INFECTIONS Sep 8, 2008 Abandoned
Array ( [id] => 6534780 [patent_doc_number] => 20100204110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'USE OF A PEPTIDE AS A THERAPEUTIC AGENT' [patent_app_type] => utility [patent_app_number] => 12/677390 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35693 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204110.pdf [firstpage_image] =>[orig_patent_app_number] => 12677390 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/677390
USE OF A PEPTIDE AS A THERAPEUTIC AGENT Sep 8, 2008 Abandoned
Array ( [id] => 6518679 [patent_doc_number] => 20100216976 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'Sodium-independent transporter carrying acidic amino acid and its gene' [patent_app_type] => utility [patent_app_number] => 12/228769 [patent_app_country] => US [patent_app_date] => 2008-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9632 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216976.pdf [firstpage_image] =>[orig_patent_app_number] => 12228769 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/228769
Sodium-independent transporter carrying acidic amino acid and its gene Aug 14, 2008 Abandoned
Array ( [id] => 8577902 [patent_doc_number] => 08344112 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-01 [patent_title] => 'IGF-1R specific antibodies useful in the detection and diagnosis of cellular proliferative disorders' [patent_app_type] => utility [patent_app_number] => 12/670863 [patent_app_country] => US [patent_app_date] => 2008-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 20 [patent_no_of_words] => 50634 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12670863 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/670863
IGF-1R specific antibodies useful in the detection and diagnosis of cellular proliferative disorders Jul 24, 2008 Issued
Array ( [id] => 5563721 [patent_doc_number] => 20090136573 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Methods for Making and Delivering Rho-Antagonist Tissue Adhesive Formulations to the Injured Mammalian Central and Peripheral Nervous Systems and uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/175268 [patent_app_country] => US [patent_app_date] => 2008-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15720 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20090136573.pdf [firstpage_image] =>[orig_patent_app_number] => 12175268 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/175268
Methods for Making and Delivering Rho-Antagonist Tissue Adhesive Formulations to the Injured Mammalian Central and Peripheral Nervous Systems and uses Thereof Jul 16, 2008 Abandoned
Array ( [id] => 8017627 [patent_doc_number] => 08138317 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-20 [patent_title] => 'Purification of pegylated polypeptides' [patent_app_type] => utility [patent_app_number] => 12/218545 [patent_app_country] => US [patent_app_date] => 2008-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8376 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 240 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/138/08138317.pdf [firstpage_image] =>[orig_patent_app_number] => 12218545 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/218545
Purification of pegylated polypeptides Jul 15, 2008 Issued
Array ( [id] => 6270716 [patent_doc_number] => 20100254983 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'USES OF RAGE ANTAGONISTS FOR TREATING OBESITY AND RELATED DISEASES' [patent_app_type] => utility [patent_app_number] => 12/451894 [patent_app_country] => US [patent_app_date] => 2008-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12900 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20100254983.pdf [firstpage_image] =>[orig_patent_app_number] => 12451894 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/451894
USES OF RAGE ANTAGONISTS FOR TREATING OBESITY AND RELATED DISEASES Jun 5, 2008 Abandoned
Array ( [id] => 5507990 [patent_doc_number] => 20090081197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'Methods for Selection of Melanocortin Receptor-Specific Agents for Treatment of Obesity' [patent_app_type] => utility [patent_app_number] => 12/130299 [patent_app_country] => US [patent_app_date] => 2008-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25762 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20090081197.pdf [firstpage_image] =>[orig_patent_app_number] => 12130299 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/130299
Methods for Selection of Melanocortin Receptor-Specific Agents for Treatment of Obesity May 29, 2008 Abandoned
Array ( [id] => 5295950 [patent_doc_number] => 20090010876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'VISFATIN AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/123988 [patent_app_country] => US [patent_app_date] => 2008-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 27419 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20090010876.pdf [firstpage_image] =>[orig_patent_app_number] => 12123988 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/123988
VISFATIN AND USES THEREOF May 19, 2008 Abandoned
Array ( [id] => 5585468 [patent_doc_number] => 20090104670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'N-carbobenzyloxy (N-CBZ)-deprotecting enzyme and uses therefor' [patent_app_type] => utility [patent_app_number] => 12/150544 [patent_app_country] => US [patent_app_date] => 2008-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20433 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20090104670.pdf [firstpage_image] =>[orig_patent_app_number] => 12150544 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/150544
N-carbobenzyloxy (N-CBZ)-deprotecting enzyme and uses therefor Apr 27, 2008 Issued
Array ( [id] => 4792189 [patent_doc_number] => 20080293163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Methods to identify compounds that modulate rage' [patent_app_type] => utility [patent_app_number] => 12/080948 [patent_app_country] => US [patent_app_date] => 2008-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 9905 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293163.pdf [firstpage_image] =>[orig_patent_app_number] => 12080948 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/080948
Methods to identify compounds that modulate rage Apr 6, 2008 Abandoned
Array ( [id] => 5527201 [patent_doc_number] => 20090197278 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2009-08-06 [patent_title] => 'Antibodies to hADA2' [patent_app_type] => utility [patent_app_number] => 12/036846 [patent_app_country] => US [patent_app_date] => 2008-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 14548 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0197/20090197278.pdf [firstpage_image] =>[orig_patent_app_number] => 12036846 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/036846
Antibodies to hADA2 Feb 24, 2008 Abandoned
Array ( [id] => 5527201 [patent_doc_number] => 20090197278 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2009-08-06 [patent_title] => 'Antibodies to hADA2' [patent_app_type] => utility [patent_app_number] => 12/036846 [patent_app_country] => US [patent_app_date] => 2008-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 14548 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0197/20090197278.pdf [firstpage_image] =>[orig_patent_app_number] => 12036846 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/036846
Human Genes, Sequences and Expression Products Feb 24, 2008 Abandoned
Menu